According to GlobalData’s medical device pipeline database, 12 Inflammation and Infection Detection devices are in various stages of development globally. GlobalData’s report Inflammation and Infection Detection provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, eight are in active development, while the remaining four are in an inactive stage of development. All devices are in the early stages of development.
Diagnostic imaging devices are used for the visualization of structural and functional patterns of organs or tissues. Computed Tomography (CT) Systems, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems, X-ray Systems, Bone Densitometers, Angio Suites, Contrast Media Injectors, Accessories, Contrast Agents, Radiopharmaceuticals and C-arms are covered under this market. An inflammation and infection detection radiopharmaceutical agent is a radioactive agent that is used to image inflammation and infection in the body. These agents are typically injected into the bloodstream and travel to the areas of inflammation or infection. Once there, they emit radiation that can be detected by a scanner. This allows doctors to see how much inflammation or infection is present and to identify the location of the inflammation or infection.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Inflammation and Infection Detection pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Inflammation and Infection Detection devices. Overall, most of these Inflammation and Infection Detection pipeline devices are being developed by private entities.
Key players involved in the active development of Inflammation and Infection Detection include Emory University, Emory University, Cell>Point, Chronus Pharmaceuticals, Society of Nuclear Medicine and Molecular Imaging, Stanford University, Stanford University, University of California Los Angeles, University of Louisville and University of Pittsburgh.
For a complete picture of the developmental pipeline for Inflammation and Infection Detection devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
